Hospira’s Inflectra becomes Australia’s first mAb biosimilar
The Australian regulator has approved Hospira’s Inflectra (infliximab), the country’s first biosimilar of a monoclonal antibody.
Archives for August 20, 2015
$47m innovation facility built in Nottingham, UK
The UK’s BioCity in Nottingham is adding a £30m ($47m) facility to house life science start-ups including CROs. The site will also become a hunting ground for a soon-to-launch venture capital fund which will invest in the SME tenants.
Diamond lights path to new antibiotic targets according to researchers
A protein called sigma54 that triggers bacterial stress responses to antibiotics could be a target for new anti-infectives say scientists.
UK bioindustry group calls for Government biomedical catalyst scheme to continue
The UK’s Biomedical Catalyst funding scheme encourages investors to back innovative biopharma research and should be continued according to the BioIndustry Association (BIA).